Sterility assurance tech dev Verrix raises $8m in Series B

Sterility assurance device developer  Verrix  said today that it raised $8 million in a Series B round of financing, lifting the total the company has raised so far to $17.5 million.  The San Clemente, Calif.-based company said that funding from the offering will support finalizing the development, regulatory submission and eventual commercialization of its Verrix EVA biological indicator system…

Sterility assurance device developer Verrix said today that it raised $8 million in a Series B round of financing, lifting the total the company has raised so far to $17.5 million.

The San Clemente, Calif.-based company said that funding from the offering will support finalizing the development, regulatory submission and eventual commercialization of its Verrix EVA biological indicator system…